Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial

The Lancet

Volumn 375, Issue 9729, 2010, Pages 1885-1895

  Strang, John ^a,b   Metrebian, Nicola ^a   Lintzeris, Nicholas ^a,b,c   Potts, Laura ^a   Carnwath, Tom ^d   Mayet, Soraya ^a,b   Williams, Hugh ^e   Zador, Deborah ^a,b   Evers, Richard ^f   Groshkova, Teodora ^a   Charles, Vikki ^a   Martin, Anthea ^a   Forzisi, Luciana ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d The Royal College of Psychiatrists   (United Kingdom)

^e SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^f KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DIAMORPHINE; METHADONE; PARACETAMOL;

ABSCESS; ADULT; ANGINA PECTORIS; APPENDICITIS; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HEART ARRHYTHMIA; HEROIN DEPENDENCE; HUMAN; LEG FRACTURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SEIZURE; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM; URINALYSIS; WRIST FRACTURE;

EID: 77952737861     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60349-2     Document Type: Article

References (29)

1. Lintzeris N. Prescription of heroin for the management of heroin dependence. CNS Drugs 23 (2009) 463-476
2. Perneger T.V., Giner F., del Rio M., and Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 317 (1998) 13-18
3. van den Brink W., Hendriks V.M., Blanken P., Koeter M.W., van Zwieten B.J., and van Ree J.M. Medical prescription of heroin to treatment resistant heroin addicts: two randomised trials. BMJ 327 (2003) 310-316
4. March J.C., Oviedo-Joekes E., Perea-Milla E., Carrasco F., and the PEPSA Team. Controlled trial of prescribed heroin in the treatment of opioid addiction. J Subst Abuse Treat 31 (2006) 203-211
5. Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., and Naber N. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry 191 (2007) 55-62
6. Oviedo-Joekes E., Brissette S., Marsh D.C., et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 361 (2009) 777-786
7. Ferri M., Davoli M., and Perucci C.A. Heroin maintenance treatment for chronic heroin dependent individuals: a Cochrane systematic review of effectiveness. J Subst Abuse Treat 30 (2006) 63-72
8. Strang J., Sheidan J., and Barber N. Prescribing injectable and oral methadone to opiate addicts: results from the 1995 national postal survey of community pharmacies in England and Wales. BMJ 313 (1996) 270-272
9. Zador D. Injectable opiate maintenance in the UK; is it good clinical practice?. Addiction 96 (2001) 547-553
10. Mitcheson M. Uncertainty with the drug clinics in the 1970s. In: Strang J., and Gossop M. (Eds). Heroin addiction and the British system: treatment and other responses vol 2 (2005), Routledge, Oxon, UK 41-52
11. Sell L., and Zador D. Patients prescribed injectable heroin or methadone-their opinions and experiences of treatment. Addiction 99 (2004) 442-449
12. Witton J., Keaney F., and Strang J. They do things differently over there: doctors, drugs and the "British system" of treating opiate addiction. J Drug Issues 35 (2005) 779-797
13. Metrebian N., Carnwath T., Stimson G.V., and Soltz T. Survey of doctors prescribing diamorphine (heroin) to opiate dependent drug users in the United Kingdom. Addiction 97 (2002) 1155-1161
14. Uchtenhagen A., Dobler-Mikola A., Steffen T., Gutzwiller R., Blättler R., and Pfeifer S. Prescription of narcotics for heroin addicts: main results of the Swiss National Cohort Study (1999), Karger, New York, NY
15. Home Office. Updated Drug Strategy 2002 (2002), Home Office, London 56
16. Lintzeris N., Strang J., Metrebian N., et al., RIOTT Group. Methodology for the Randomised Injecting Opiate Treatment Trial (RIOTT): evaluating injectable methadone and injectable heroin treatment versus optimised oral methadone treatment in the UK. Harm Reduct J 3 (2006) 28-33
17. Paterson S., Lintzeris N., Mitchell T.B., Cordero R., Nestor L., and Strang J. Validation of techniques to detect illicit heroin use in patients prescribed pharmaceutical heroin for the management of opioid dependence. Addiction 100 (2005) 1832-1839
18. Paterson S., and Cordero R. Comparison of the various opiate alkaloid contaminants and their metabolites found in illicit heroin with 6-monoacetyl morphine as indicators of heroin ingestion. J Anal Toxicol 30 (2006) 267-273
19. Metrebian N., Shanahan W., Stimson G.V., et al. Prescribing drug of choice to opiate dependent drug users: a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. Drug Alcohol Rev 20 (2001) 267-276
20. Strang J., Marsden J., Cummins M., et al. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcomes. Addiction 95 (2000) 1631-1645
21. Rubin D.B. Multiple imputation for non response in surveys (1987), J Wiley & Sons, New York
22. Altman D.G. Confidence intervals for the number needed to treat. BMJ 317 (1998) 1309-1312
23. Strang J. The roles of prescribing. In: Strang J., and Stimson G. (Eds). AIDS and drug misuse: the challenge for policy and practice in the 1990s (1990), Routledge, London 142-152
24. Tober G. Dependence on methadone: the danger lurking behind the prescription. In: Tober G., and Strang J. (Eds). Methadone matters: evolving community methadone treatment of opiate addiction (2003), Martin Dunitz, London 131-140
25. Zador D. Last call for injectable opiate maintenance: in pursuit of an evidence base for good clinical practice. In: Strang J., and Gossop M. (Eds). Heroin addiction and the British system: treatment and policy responses vol 2 (2005), Routledge, London 121-130
26. Strang J., Ruben S., Farrell M., Witton J., Keaney F., and Gossop M. The history of prescribing heroin and other injectable drugs as addiction treatment in the UK. In: Strang J., and Gossop M. (Eds). Heroin addiction and the British system: treatment and policy responses vol 2 (2005), Routledge, London 1-16
27. Rehm J., Gschwend P., Steffen T., Gutzwiller F., Dobler-Mikola A., and Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 358 (2001) 1417-1420
28. Verthein U., Bonorden-Kleij K., Degkwitz P., et al. Long-term effects of heroin-assisted treatment in Germany. Addiction 103 (2008) 960-966
29. HM Government. Drugs: protecting families and communities. The 2008 Drug Strategy (2008), HM Government, London